Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Research Abstract |
Diabetes mellitus was induced by STZ administration to the SD rat. The 2 Z, 3 E-6-bromoindirubin-3-oxime(BIO), a GSK-3 s inhibitor, was administrated peritoneally. In diabetic rat the urinary protein excretion was reduced by BIO administration. The TGF-s1 mRNA expression of glomeruli was suppressed by BIO treatment. It was suggested that the suppression of TGF-s1 by BIO could be involved the amelioration of diabetic nephropathy.
|